Machine learning identified EGFR alterations, including low- and high-grade gliomas not diagnosed with the current guidelines, with an AUC of 0.77–0.90 and accuracy of 0.66–0.82 (142, 150, 151). This evidence concerns the gene EGFR and central nervous system cancer.